Status and phase
Conditions
Treatments
About
The purpose of this research study is to compare the efficacy and safety of higher doses of rituximab to a combination of standard doses of Rituxan + CVP (Cyclophosphamide, Vincristine, and Prednisone) in patients with chronic Idiopathic Thrombocytopenic Purpura (ITP who did not respond to or relapsed after standard doses of rituximab.
Full description
Primary Objectives
Secondary Objectives
Sex
Ages
Volunteers
Inclusion criteria
Patients will be eligible to participate in the study if they:
Exclusion criteria
Male and female subjects will be ineligible to participate if they:
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal